Novavax Inc (NVAX)
5.15
-0.14
(-2.65%)
USD |
NASDAQ |
Mar 18, 16:00
5.15
0.00 (0.00%)
After-Hours: 05:43
Novavax Market Cap: 720.76M for March 18, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
March 18, 2024 | 720.76M |
March 15, 2024 | 740.35M |
March 14, 2024 | 696.97M |
March 13, 2024 | 734.75M |
March 12, 2024 | 708.16M |
March 11, 2024 | 717.96M |
March 08, 2024 | 762.74M |
March 07, 2024 | 785.14M |
March 06, 2024 | 785.14M |
March 05, 2024 | 779.54M |
March 04, 2024 | 768.34M |
March 01, 2024 | 754.35M |
February 29, 2024 | 691.37M |
February 28, 2024 | 617.19M |
February 27, 2024 | 842.52M |
February 26, 2024 | 769.74M |
February 23, 2024 | 740.35M |
February 22, 2024 | 680.79M |
February 21, 2024 | 555.23M |
February 20, 2024 | 576.16M |
February 16, 2024 | 580.34M |
February 15, 2024 | 599.87M |
February 14, 2024 | 571.97M |
February 13, 2024 | 544.07M |
February 12, 2024 | 578.95M |
Date | Value |
---|---|
February 09, 2024 | 562.21M |
February 08, 2024 | 528.73M |
February 07, 2024 | 527.33M |
February 06, 2024 | 548.26M |
February 05, 2024 | 524.54M |
February 02, 2024 | 548.26M |
February 01, 2024 | 560.81M |
January 31, 2024 | 558.02M |
January 30, 2024 | 562.21M |
January 29, 2024 | 584.53M |
January 26, 2024 | 566.39M |
January 25, 2024 | 571.97M |
January 24, 2024 | 565.00M |
January 23, 2024 | 594.29M |
January 22, 2024 | 583.13M |
January 19, 2024 | 565.00M |
January 18, 2024 | 573.37M |
January 17, 2024 | 586.62M |
January 16, 2024 | 605.46M |
January 12, 2024 | 638.94M |
January 11, 2024 | 636.15M |
January 10, 2024 | 675.21M |
January 09, 2024 | 671.02M |
January 08, 2024 | 718.45M |
January 05, 2024 | 697.53M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
96.17M
Minimum
Aug 12 2019
22.99B
Maximum
Feb 08 2021
4.699B
Average
1.463B
Median
Nov 09 2022
Market Cap Benchmarks
Pfizer Inc | 156.53B |
Moderna Inc | 39.83B |
Abbott Laboratories | 195.10B |
Becton Dickinson & Co | 68.68B |
QuidelOrtho Corp | 3.276B |
Market Cap Related Metrics
PS Ratio | 0.7753 |
Price | 5.15 |
Earnings Yield | -108.0% |